Modeling the complex pathology of Alzheimer's disease in Drosophila

Experimental Neurology

Volumn 274, Issue , 2015, Pages 58-71

  Fernandez Funez, Pedro ^a,b   de Mena, Lorena ^a   Rincon Limas, Diego E ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; APP; A 42; Disease models; Drosophila; Genetics; Neurodegeneration; Pathology; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; TAU PROTEIN; APP PROTEIN, HUMAN; DROSOPHILA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CELL MIGRATION; DROSOPHILA MELANOGASTER; GENETIC SCREENING; GENOME ANALYSIS; MICROTUBULE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; TAUOPATHY; ANIMAL; DISEASE MODEL; DROSOPHILA; GENETICS; HUMAN; NEUROFIBRILLARY TANGLE; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; DROSOPHILA PROTEINS; HUMANS; NEUROFIBRILLARY TANGLES;

EID: 84947037627     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2015.05.013     Document Type: Article

References (163)

1. Acerra N., Kad N.M., Griffith D.A., Ott S., Crowther D.C., Mason J.M. Retro-inversal of intracellular selected beta-amyloid-interacting peptides: implications for a novel Alzheimer's disease treatment. Biochemistry 2014, 53:2101-2111.
2. Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D., Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F., George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N., Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C., Rogers Y.H., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Gabor G.L., Abril J.F., Agbayani A., An H.J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M., Harris N.L., Harvey D., Heiman T.J., Hernandez J.R., Houck J., Hostin D., Houston K.A., Howland T.J., Wei M.H., Ibegwam C., Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D., Kraft C., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A., Li J., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G., Reinert K., Remington K., Saunders R.D., Scheeler F., Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T., Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.Y., Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C. The genome sequence of Drosophila melanogaster. Science 2000, 287:2185-2195.
3. Ali Y.O., Ruan K., Zhai R.G. NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy. Hum. Mol. Genet. 2012, 21:237-250.
4. Allan K., Perez K.A., Barnham K.J., Camakaris J., Burke R. A commonly used Drosophila model of Alzheimer's disease generates an aberrant species of amyloid-beta with an additional N-terminal glutamine residue. FEBS Lett. 2014, 588:3739-3743.
5. Ambegaokar S.S., Jackson G.R. Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum. Mol. Genet. 2011, 20:4947-4977.
6. Andreadis A. Tau splicing and the intricacies of dementia. J. Cell. Physiol. 2012, 227:1220-1225.
7. Baell J., Walters M.A. Chemistry: chemical con artists foil drug discovery. Nature 2014, 513:481-483.
8. Bassett A.R., Tibbit C., Ponting C.P., Liu J.L. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep. 2013, 4:220-228.
9. Beharry C., Cohen L.S., Di J., Ibrahim K., Briffa-Mirabella S., Alonso Adel C. Tau-induced neurodegeneration: mechanisms and targets. Neurosci. Bull. 2014, 30:346-358.
10. Bellen H.J., Tong C., Tsuda H. 100years of Drosophila research and its impact on vertebrate neuroscience: a history lesson for the future. Nat. Rev. Neurosci. 2010, 11:514-522.
11. Benilova I., Karran E., De Strooper B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 2012, 15:349-357.
12. Bilen J., Bonini N.M. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. 2007, 3:1950-1964.
13. Blard O., Feuillette S., Bou J., Chaumette B., Frebourg T., Campion D., Lecourtois M. Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Hum. Mol. Genet. 2007, 16:555-566.
14. Bloom G.S. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014, 71:505-508.
15. Blurton-Jones M., Spencer B., Michael S., Castello N.A., Agazaryan A.A., Davis J.L., Muller F.J., Loring J.F., Masliah E., LaFerla F.M. Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models. Stem Cell Res. Ther. 2014, 5:46.
16. Bolkan B.J., Triphan T., Kretzschmar D. Beta-secretase cleavage of the fly amyloid precursor protein is required for glial survival. J. Neurosci. 2012, 32:16181-16192.
17. Brand A.H., Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993, 118:401-415.
18. Brorsson A.C., Bolognesi B., Tartaglia G.G., Shammas S.L., Favrin G., Watson I., Lomas D.A., Chiti F., Vendruscolo M., Dobson C.M., Crowther D.C., Luheshi L.M. Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide. Biophys. J. 2010, 98:1677-1684.
19. Caesar I., Jonson M., Nilsson K.P., Thor S., Hammarstrom P. Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila. PLoS One 2012, 7:e31424.
20. Cao X., Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120.
21. Cao W., Song H.J., Gangi T., Kelkar A., Antani I., Garza D., Konsolaki M. Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila. Genetics 2008, 178:1457-1471.
22. Carmine-Simmen K., Proctor T., Tschape J., Poeck B., Triphan T., Strauss R., Kretzschmar D. Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol. Dis. 2009, 33:274-281.
23. Casas-Tinto S., Zhang Y., Sanchez-Garcia J., Gomez-Velazquez M., Rincon-Limas D.E., Fernandez-Funez P. The ER stress factor XBP1s prevents amyloid-beta neurotoxicity. Hum. Mol. Genet. 2011, 20:2144-2160.
24. Chakraborty R., Vepuri V., Mhatre S.D., Paddock B.E., Miller S., Michelson S.J., Delvadia R., Desai A., Vinokur M., Melicharek D.J., Utreja S., Khandelwal P., Ansaloni S., Goldstein L.E., Moir R.D., Lee J.C., Tabb L.P., Saunders A.J., Marenda D.R. Characterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects. PLoS ONE 2011, 6:e20799.
25. Chatterjee S., Sang T.K., Lawless G.M., Jackson G.R. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet. 2009, 18:164-177.
26. Chen K.F., Possidente B., Lomas D.A., Crowther D.C. The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease. Dis. Model. Mech. 2014, 7:445-458.
27. Chiang H.C., Iijima K., Hakker I., Zhong Y. Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions. FASEB J. 2009, 23:1969-1977.
28. Chiang H.C., Wang L., Xie Z., Yau A., Zhong Y. PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7060-7065.
29. Chien S., Reiter L.T., Bier E., Gribskov M. Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res. 2002, 30:149-151.
30. Coburger I., Hoefgen S., Than M.E. The structural biology of the amyloid precursor protein APP - a complex puzzle reveals its multi-domain architecture. Biol. Chem. 2014, 395:485-498.
31. Colodner K.J., Feany M.B. Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy. J. Neurosci. 2010, 30:16102-16113.
32. Costa R., Speretta E., Crowther D.C., Cardoso I. Testing the therapeutic potential of doxycycline in a Drosophila melanogaster model of Alzheimer disease. J. Biol. Chem. 2011, 286:41647-41655.
33. Cowan C.M., Bossing T., Page A., Shepherd D., Mudher A. Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol. 2010, 120:593-604.
34. Crowther D.C., Kinghorn K.J., Miranda E., Page R., Curry J.A., Duthie F.A., Gubb D.C., Lomas D.A. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 2005, 132:123-135.
35. Davis R.L. Olfactory memory formation in Drosophila: from molecular to systems neuroscience. Annu. Rev. Neurosci. 2005, 28:275-302.
36. Dias-Santagata D., Fulga T.A., Duttaroy A., Feany M.B. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Invest. 2007, 117:236-245.
37. DuBoff B., Gotz J., Feany M.B. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 2012, 75:618-632.
38. Fang L., Duan J., Ran D., Fan Z., Yan Y., Huang N., Gu H., Zhu Y. Amyloid-beta depresses excitatory cholinergic synaptic transmission in Drosophila. Neurosci. Bull. 2012, 28:585-594.
39. Favrin G., Bean D.M., Bilsland E., Boyer H., Fischer B.E., Russell S., Crowther D.C., Baylis H.A., Oliver S.G., Giannakou M.E. Identification of novel modifiers of Abeta toxicity by transcriptomic analysis in the fruitfly. Sci. Rep. 2013, 3:3512.
40. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., She W.C., Luchak J.M., Martinez P., Turiegano E., Benito J., Capovilla M., Skinner P.J., McCall A., Canal I., Orr H.T., Zoghbi H.Y., Botas J. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 2000, 408:101-106.
41. Finelli A., Kelkar A., Song H.J., Yang H., Konsolaki M. A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Mol. Cell. Neurosci. 2004, 26:365-375.
42. Folwell J., Cowan C.M., Ubhi K.K., Shiabh H., Newman T.A., Shepherd D., Mudher A. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Exp. Neurol. 2010, 223:401-409.
43. Fossgreen A., Bruckner B., Czech C., Masters C.L., Beyreuther K., Paro R. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc Natl Acad Sci U S A 1998, 95:13703-13708.
44. Frost B., Hemberg M., Lewis J., Feany M.B. Tau promotes neurodegeneration through global chromatin relaxation. Nat. Neurosci. 2014, 17:357-366.
45. Fulga T.A., Elson-Schwab I., Khurana V., Steinhilb M.L., Spires T.L., Hyman B.T., Feany M.B. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol. 2007, 9:139-148.
46. Gendron T.F., Petrucelli L. The role of tau in neurodegeneration. Mol. Neurodegener. 2009, 4:13.
47. Geng J., Xia L., Li W., Dou F. The C-terminus of tau protein plays an important role in its stability and toxicity. J Mol Neurosci 2015, 55:251-259.
48. Gistelinck M., Lambert J.C., Callaerts P., Dermaut B., Dourlen P. Drosophila models of tauopathies: what have we learned?. Int. J. Alzheimers Dis. 2012, 2012:970980.
49. Goguel V., Belair A.L., Ayaz D., Lampin-Saint-Amaux A., Scaplehorn N., Hassan B.A., Preat T. Drosophila amyloid precursor protein-like is required for long-term memory. J. Neurosci. 2011, 31:1032-1037.
50. Golde T.E., Borchelt D.R., Giasson B.I., Lewis J. Thinking laterally about neurodegenerative proteinopathies. J. Clin. Invest. 2013, 123:1847-1855.
51. Gotz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 2001, 293:1491-1495.
52. Gratz S.J., Cummings A.M., Nguyen J.N., Hamm D.C., Donohue L.K., Harrison M.M., Wildonger J., O'Connor-Giles K.M. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 2013, 194:1029-1035.
53. Greeve I., Kretzschmar D., Tschape J.A., Beyn A., Brellinger C., Schweizer M., Nitsch R.M., Reifegerste R. Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J. Neurosci. 2004, 24:3899-3906.
54. Gross G.G., Feldman R.M., Ganguly A., Wang J., Yu H., Guo M. Role of X11 and ubiquilin as in vivo regulators of the amyloid precursor protein in Drosophila. PLoS ONE 2008, 3:e2495.
55. Gunawardena S., Goldstein L.S. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 2001, 32:389-401.
56. Gunawardena S., Yang G., Goldstein L.S. Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo. Hum. Mol. Genet. 2013, 22:3828-3843.
57. Hall A.M., Roberson E.D. Mouse models of Alzheimer's disease. Brain Res. Bull. 2012, 88:3-12.
58. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T., Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994, 369:488-491.
59. Hardin P.E. The circadian timekeeping system of Drosophila. Curr. Biol. 2005, 15:R714-R722.
60. Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 2009, 110:1129-1134.
61. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
62. Hermansson E., Schultz S., Crowther D., Linse S., Winblad B., Westermark G., Johansson J., Presto J. The chaperone domain BRICHOS prevents CNS toxicity of amyloid-beta peptide in Drosophila melanogaster. Dis. Model. Mech. 2014, 7:659-665.
63. Hong Y.K., Lee S., Park S.H., Lee J.H., Han S.Y., Kim S.T., Kim Y.K., Jeon S., Koo B.S., Cho K.S. Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer's disease model. Biochem. Biophys. Res. Commun. 2012, 419:49-53.
64. Hu Y., Han Y., Wang X., Xue L. Aging-related neurodegeneration eliminates male courtship choice in Drosophila. Neurobiol. Aging 2014, 35:2174-2178.
65. Hua H., Munter L., Harmeier A., Georgiev O., Multhaup G., Schaffner W. Toxicity of Alzheimer's disease-associated Abeta peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Biol. Chem. 2011, 392:919-926.
66. Huang J.K., Ma P.L., Ji S.Y., Zhao X.L., Tan J.X., Sun X.J., Huang F.D. Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer's disease. Neurobiol. Dis. 2013, 51:161-167.
67. Huang Y., Wu Z., Cao Y., Lang M., Lu B., Zhou B. Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation. Cell Rep. 2014, 8:831-842.
68. Hurtado D.E., Molina-Porcel L., Iba M., Aboagye A.K., Paul S.M., Trojanowski J.Q., Lee V.M. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am. J. Pathol. 2010, 177:1977-1988.
69. Iijima K., Liu H.P., Chiang A.S., Hearn S.A., Konsolaki M., Zhong Y. Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6623-6628.
70. Iijima K., Chiang H.C., Hearn S.A., Hakker I., Gatt A., Shenton C., Granger L., Leung A., Iijima-Ando K., Zhong Y. Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE 2008, 3:e1703.
71. Iijima K., Gatt A., Iijima-Ando K. Tau Ser262 phosphorylation is critical for Abeta42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Hum. Mol. Genet. 2010, 19:2947-2957.
72. Iijima-Ando K., Hearn S.A., Granger L., Shenton C., Gatt A., Chiang H.C., Hakker I., Zhong Y., Iijima K. Overexpression of neprilysin reduces Alzheimer amyloid-beta42 (Abeta42)-induced neuron loss and intraneuronal Abeta42 deposits but causes a reduction in cAMP-responsive element-binding protein-mediated transcription, age-dependent axon pathology, and premature death in Drosophila. J. Biol. Chem. 2008, 283:19066-19076.
73. Iijima-Ando K., Hearn S.A., Shenton C., Gatt A., Zhao L., Iijima K. Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 2009, 4:e8310.
74. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Wolfing H., Chieng B.C., Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Gotz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
75. Jackson G.R., Wiedau-Pazos M., Sang T.K., Wagle N., Brown C.A., Massachi S., Geschwind D.H. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 2002, 34:509-519.
76. Jahn T.R., Kohlhoff K.J., Scott M., Tartaglia G.G., Lomas D.A., Dobson C.M., Vendruscolo M., Crowther D.C. Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease. J Neurosci Methods 2011, 197:186-189.
77. Jenett A., Rubin G.M., Ngo T.T., Shepherd D., Murphy C., Dionne H., Pfeiffer B.D., Cavallaro A., Hall D., Jeter J., Iyer N., Fetter D., Hausenfluck J.H., Peng H., Trautman E.T., Svirskas R.R., Myers E.W., Iwinski Z.R., Aso Y., Depasquale G.M., Enos A., Hulamm P., Lam S.C., Li H.H., Laverty T.R., Long F., Qu L., Murphy S.D., Rokicki K., Safford T., Shaw K., Simpson J.H., Sowell A., Tae S., Yu Y., Zugates C.T. A GAL4-driver line resource for Drosophila neurobiology. Cell Rep. 2012, 2:991-1001.
78. Johnson A.A., Sarthi J., Pirooznia S.K., Reube W., Elefant F. Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer's disease model. J. Neurosci. 2013, 33:7535-7547.
79. Karch C.M., Cruchaga C., Goate A.M. Alzheimer's disease genetics: from the bench to the clinic. Neuron 2014, 83:11-26.
80. Karsten S.L., Sang T.K., Gehman L.T., Chatterjee S., Liu J., Lawless G.M., Sengupta S., Berry R.W., Pomakian J., Oh H.S., Schulz C., Hui K.S., Wiedau-Pazos M., Vinters H.V., Binder L.I., Geschwind D.H., Jackson G.R. A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration. Neuron 2006, 51:549-560.
81. Khurana V., Lu Y., Steinhilb M.L., Oldham S., Shulman J.M., Feany M.B. TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol 2006, 16:230-241.
82. Khurana V., Elson-Schwab I., Fulga T.A., Sharp K.A., Loewen C.A., Mulkearns E., Tyynela J., Scherzer C.R., Feany M.B. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 2010, 6:e1001026.
83. Khurana V., Merlo P., DuBoff B., Fulga T.A., Sharp K.A., Campbell S.D., Gotz J., Feany M.B. A neuroprotective role for the DNA damage checkpoint in tauopathy. Aging Cell 2012, 11:360-362.
84. Kidd J.F., Sattelle D.B. The effects of amyloid peptides on A-type K(+) currents of Drosophila larval cholinergic neurons: modeled actions on firing properties. Invertebr. Neurosci. 2006, 6:207-213.
85. Kidd J.F., Brown L.A., Sattelle D.B. Effects of amyloid peptides on A-type K+ currents of Drosophila larval cholinergic neurons. J. Neurobiol. 2006, 66:476-487.
86. Kinghorn K.J., Crowther D.C., Sharp L.K., Nerelius C., Davis R.L., Chang H.T., Green C., Gubb D.C., Johansson J., Lomas D.A. Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease. J. Biol. Chem. 2006, 281:29268-29277.
87. Kondo S. New horizons in genome engineering of Drosophila melanogaster. Genes Genet. Syst. 2014, 89:3-8.
88. Kosmidis S., Grammenoudi S., Papanikolopoulou K., Skoulakis E.M. Differential effects of Tau on the integrity and function of neurons essential for learning in Drosophila. J. Neurosci. 2010, 30:464-477.
89. Kruppa A.J., Ott S., Chandraratna D.S., Irving J.A., Page R.M., Speretta E., Seto T., Camargo L.M., Marciniak S.J., Lomas D.A., Crowther D.C. Suppression of Abeta toxicity by puromycin-sensitive aminopeptidase is independent of its proteolytic activity. Biochim. Biophys. Acta 2013, 1832:2115-2126.
90. Lai S.L., Lee T. Genetic mosaic with dual binary transcriptional systems in Drosophila. Nat. Neurosci. 2006, 9:703-709.
91. Lang M., Fan Q., Wang L., Zheng Y., Xiao G., Wang X., Wang W., Zhong Y., Zhou B. Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Abeta42-induced Alzheimer's disease-like symptoms. Neurobiol. Aging 2013, 34:2604-2612.
92. Leroy K., Ando K., Laporte V., Dedecker R., Suain V., Authelet M., Heraud C., Pierrot N., Yilmaz Z., Octave J.N., Brion J.P. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. Am. J. Pathol. 2012, 181:1928-1940.
93. Leyssen M., Ayaz D., Hebert S.S., Reeve S., De Strooper B., Hassan B.A. Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. EMBO J. 2005, 24:2944-2955.
94. Li Y., Liu T., Peng Y., Yuan C., Guo A. Specific functions of Drosophila amyloid precursor-like protein in the development of nervous system and nonneural tissues. J. Neurobiol. 2004, 61:343-358.
95. Lin J.Y., Wang W.A., Zhang X., Liu H.Y., Zhao X.L., Huang F.D. Intraneuronal accumulation of Abeta42 induces age-dependent slowing of neuronal transmission in Drosophila. Neurosci. Bull. 2014, 30:185-190.
96. Ling D., Song H.J., Garza D., Neufeld T.P., Salvaterra P.M. Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS ONE 2009, 4:e4201.
97. Liu B., Moloney A., Meehan S., Morris K., Thomas S.E., Serpell L.C., Hider R., Marciniak S.J., Lomas D.A., Crowther D.C. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 2011, 286:4248-4256.
98. Loewen C.A., Feany M.B. The unfolded protein response protects from tau neurotoxicity in vivo. PLoS One 2010, 5.
99. Long D.M., Blake M.R., Dutta S., Holbrook S.D., Kotwica-Rolinska J., Kretzschmar D., Giebultowicz J.M. Relationships between the circadian system and Alzheimer's disease-like symptoms in Drosophila. PLoS One 2014, 9:e106068.
100. Luheshi L.M., Tartaglia G.G., Brorsson A.C., Pawar A.P., Watson I.E., Chiti F., Vendruscolo M., Lomas D.A., Dobson C.M., Crowther D.C. Systematic in vivo analysis of the intrinsic determinants of amyloid beta pathogenicity. PLoS Biol. 2007, 5:e290.
101. Luheshi L.M., Hoyer W., de Barros T.P., van Dijk Hard I., Brorsson A.C., Macao B., Persson C., Crowther D.C., Lomas D.A., Stahl S., Dobson C.M., Hard T. Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. PLoS Biol. 2010, 8:e1000334.
102. Luo L.Q., Martin-Morris L.E., White K. Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J. Neurosci. 1990, 10:3849-3861.
103. Luo L., Tully T., White K. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 1992, 9:595-605.
104. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., Verma I.M., Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 2003, 23:1992-1996.
105. Martin-Morris L.E., White K. The Drosophila transcript encoded by the beta-amyloid protein precursor-like gene is restricted to the nervous system. Development 1990, 110:185-195.
106. Merdes G., Soba P., Loewer A., Bilic M.V., Beyreuther K., Paro R. Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila. Embo J 2004, 23:4082-4095.
107. Merlo P., Frost B., Peng S., Yang Y.J., Park P.J., Feany M. p53 prevents neurodegeneration by regulating synaptic genes. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:18055-18060.
108. Mershin A., Pavlopoulos E., Fitch O., Braden B.C., Nanopoulos D.V., Skoulakis E.M. Learning and memory deficits upon TAU accumulation in Drosophila mushroom body neurons. Learn Mem 2004, 11:277-287.
109. Mhatre S.D., Michelson S.J., Gomes J., Tabb L.P., Saunders A.J., Marenda D.R. Development and characterization of an aged onset model of Alzheimer's disease in Drosophila melanogaster. Exp. Neurol. 2014, 261:772-781.
110. Mohr S.E., Hu Y., Kim K., Housden B.E., Perrimon N. Resources for functional genomics studies in Drosophila melanogaster. Genetics 2014, 197:1-18.
111. Mora N., Almudi I., Alsina B., Corominas M., Serras F. beta amyloid protein precursor-like (Appl) is a Ras1/MAPK-regulated gene required for axonal targeting in Drosophila photoreceptor neurons. J. Cell Sci. 2013, 126:53-59.
112. Morris M., Maeda S., Vossel K., Mucke L. The many faces of tau. Neuron 2011, 70:410-426.
113. Mudher A., Shepherd D., Newman T.A., Mildren P., Jukes J.P., Squire A., Mears A., Drummond J.A., Berg S., MacKay D., Asuni A.A., Bhat R., Lovestone S. GSK-3beta inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila. Mol. Psychiatry 2004, 9:522-530.
114. Nerelius C., Sandegren A., Sargsyan H., Raunak R., Leijonmarck H., Chatterjee U., Fisahn A., Imarisio S., Lomas D.A., Crowther D.C., Stromberg R., Johansson J. Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9191-9196.
115. Ng C.F., Ko C.H., Koon C.M., Xian J.W., Leung P.C., Fung K.P., Chan H.Y., Lau C.B. The aqueous extract of rhizome of gastrodia elata protected Drosophila and PC12 cells against beta-amyloid-induced neurotoxicity. Evid. Based Complement. Alternat. Med. 2013, 2013:516741.
116. Nhan H.S., Chiang K., Koo E.H. The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathol. 2015, 129:1-19.
117. Nishimura I., Yang Y., Lu B. PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 2004, 116:671-682.
118. Oddo S., Caccamo A., Cheng D., Jouleh B., Torp R., LaFerla F.M. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. J. Neurochem. 2007, 102:1053-1063.
119. Overk C.R., Masliah E. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem. Pharmacol. 2014, 88:508-516.
120. Park S.H., Lee S., Hong Y.K., Hwang S., Lee J.H., Bang S.M., Kim Y.K., Koo B.S., Lee I.S., Cho K.S. Suppressive effects of SuHeXiang Wan on amyloid-beta42-induced extracellular signal-regulated kinase hyperactivation and glial cell proliferation in a transgenic Drosophila model of Alzheimer's disease. Biol. Pharm. Bull. 2013, 36:390-398.
121. Park S.J., Schertel A., Lee K.E., Han S.S. Ultra-structural analysis of the brain in a Drosophila model of Alzheimer's disease using FIB/SEM microscopy. Microscopy 2014, 63:3-13.
122. Ping Y., Hahm E.T., Waro G., Song Q., Vo-Ba D.A., Licursi A., Bao H., Ganoe L., Finch K., Tsunoda S. Linking abeta42-induced hyperexcitability to neurodegeneration, learning and motor deficits, and a shorter lifespan in an Alzheimer's model. PLoS Genet. 2015, 11:e1005025.
123. Poeck B., Strauss R., Kretzschmar D. Analysis of amyloid precursor protein function in Drosophila melanogaster. Exp. Brain Res. 2012, 217:413-421.
124. Potter C.J., Tasic B., Russler E.V., Liang L., Luo L. The Q system: a repressible binary system for transgene expression, lineage tracing, and mosaic analysis. Cell 2010, 141:536-548.
125. Pratim Bose P., Chatterjee U., Nerelius C., Govender T., Norstrom T., Gogoll A., Sandegren A., Gothelid E., Johansson J., Arvidsson P.I. Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster. J. Med. Chem. 2009, 52:8002-8009.
126. Reichert H. A tripartite organization of the urbilaterian brain: developmental genetic evidence from Drosophila. Brain Res. Bull. 2005, 66:491-494.
127. Reinecke J.B., DeVos S.L., McGrath J.P., Shepard A.M., Goncharoff D.K., Tait D.N., Fleming S.R., Vincent M.P., Steinhilb M.L. Implicating calpain in tau-mediated toxicity in vivo. PLoS One 2011, 6:e23865.
128. Reis G.F., Yang G., Szpankowski L., Weaver C., Shah S.B., Robinson J.T., Hays T.S., Danuser G., Goldstein L.S. Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila. Mol. Biol. Cell 2012, 23:1700-1714.
129. Rincon-Limas D., Jensen K., Fernandez Funez A. Drosophila models of proteinopathies: the little fly that could. Curr. Pharm. Des. 2012, 18:1108-1122.
130. Rival T., Page R.M., Chandraratna D.S., Sendall T.J., Ryder E., Liu B., Lewis H., Rosahl T., Hider R., Camargo L.M., Shearman M.S., Crowther D.C., Lomas D.A. Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur. J. Neurosci. 2009, 29:1335-1347.
131. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.Q., Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
132. Rorth P. A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:12418-12422.
133. Rosen D.R., Martin-Morris L., Luo L.Q., White K. A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:2478-2482.
134. Salminen A., Ojala J., Kauppinen A., Kaarniranta K., Suuronen T. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog. Neurobiol. 2009, 87:181-194.
135. Sanokawa-Akakura R., Cao W., Allan K., Patel K., Ganesh A., Heiman G., Burke R., Kemp F.W., Bogden J.D., Camakaris J., Birge R.B., Konsolaki M. Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One 2010, 5:e8626.
136. Sergeant N., Bretteville A., Hamdane M., Caillet-Boudin M.L., Grognet P., Bombois S., Blum D., Delacourte A., Pasquier F., Vanmechelen E., Schraen-Maschke S., Buee L. Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev. Proteomics 2008, 5:207-224.
137. Shariati S.A., De Strooper B. Redundancy and divergence in the amyloid precursor protein family. FEBS Lett. 2013, 587:2036-2045.
138. Shulman J.M., Feany M.B. Genetic modifiers of tauopathy in Drosophila. Genetics 2003, 165:1233-1242.
139. Slomnicki L.P., Lesniak W. A putative role of the amyloid precursor protein intracellular domain (AICD) in transcription. Acta Neurobiol. Exp. 2008, 68:219-228.
140. Sofola O., Kerr F., Rogers I., Killick R., Augustin H., Gandy C., Allen M.J., Hardy J., Lovestone S., Partridge L. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet. 2010, 6:e1001087.
141. Sofola-Adesakin O., Castillo-Quan J.I., Rallis C., Tain L.S., Bjedov I., Rogers I., Li L., Martinez P., Khericha M., Cabecinha M., Bahler J., Partridge L. Lithium suppresses Abeta pathology by inhibiting translation in an adult Drosophila model of Alzheimer's disease. Front. Aging Neurosci. 2014, 6:190.
142. Soldano A., Okray Z., Janovska P., Tmejova K., Reynaud E., Claeys A., Yan J., Atak Z.K., De Strooper B., Dura J.M., Bryja V., Hassan B.A. The Drosophila homologue of the amyloid precursor protein is a conserved modulator of Wnt PCP signaling. PLoS Biol. 2013, 11:e1001562.
143. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castano E.M., Frangione B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 1998, 4:822-826.
144. Speretta E., Jahn T.R., Tartaglia G.G., Favrin G., Barros T.P., Imarisio S., Lomas D.A., Luheshi L.M., Crowther D.C., Dobson C.M. Expression in drosophila of tandem amyloid beta peptides provides insights into links between aggregation and neurotoxicity. J. Biol. Chem. 2012, 287:20748-20754.
145. Stancu I.C., Vasconcelos B., Terwel D., Dewachter I. Models of beta-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism. Mol. Neurodegener. 2014, 9:51.
146. Steinhilb M.L., Dias-Santagata D., Fulga T.A., Felch D.L., Feany M.B. Tau phosphorylation sites work in concert to promote neurotoxicity in vivo. Mol. Biol. Cell 2007, 18:5060-5068.
147. Steinhilb M.L., Dias-Santagata D., Mulkearns E.E., Shulman J.M., Biernat J., Mandelkow E.M., Feany M.B. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res. 2007, 85:1271-1278.
148. Stokin G.B., Almenar-Queralt A., Gunawardena S., Rodrigues E.M., Falzone T., Kim J., Lillo C., Mount S.L., Roberts E.A., McGowan E., Williams D.S., Goldstein L.S. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Hum. Mol. Genet. 2008, 17:3474-3486.
149. Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G., Iwatsubo T. The role of presenilin cofactors in the gamma-secretase complex. Nature 2003, 422:438-441.
150. Tan L., Schedl P., Song H.J., Garza D., Konsolaki M. The Toll→NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila. PLoS One 2008, 3:e3966.
151. Tare M., Modi R.M., Nainaparampil J.J., Puli O.R., Bedi S., Fernandez-Funez P., Kango-Singh M., Singh A. Activation of JNK signaling mediates amyloid-ss-dependent cell death. PLoS One 2011, 6:e24361.
152. Thies W., Bleiler L., Alzheimer's A. 2013 Alzheimer's disease facts and figures. Alzheimers Dement. 2013, 9:208-245.
153. Torroja L., Luo L., White K. APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons. J. Neurosci. 1996, 16:4638-4650.
154. Torroja L., Chu H., Kotovsky I., White K. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr. Biol. 1999, 9:489-492.
155. Torroja L., Packard M., Gorczyca M., White K., Budnik V. The Drosophila beta-amyloid precursor protein homolog promotes synapse differentiation at the neuromuscular junction. J. Neurosci. 1999, 19:7793-7803.
156. Tschape J.A., Hammerschmied C., Muhlig-Versen M., Athenstaedt K., Daum G., Kretzschmar D. The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing. Embo. J. 2002, 21:6367-6376.
157. Venken K.J., Kasprowicz J., Kuenen S., Yan J., Hassan B.A., Verstreken P. Recombineering-mediated tagging of Drosophila genomic constructs for in vivo localization and acute protein inactivation. Nucleic Acids Res. 2008, 36:e114.
158. Wacker J., Ronicke R., Westermann M., Wulff M., Reymann K.G., Dobson C.M., Horn U., Crowther D.C., Luheshi L.M., Fandrich M. Oligomer-targeting with a conformational antibody fragment promotes toxicity in Abeta-expressing flies. Acta Neuropathol. Commun. 2014, 2:43.
159. Wentzell J.S., Bolkan B.J., Carmine-Simmen K., Swanson T.L., Musashe D.T., Kretzschmar D. Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration. Neurobiol. Dis. 2012, 46:78-87.
160. Williams D.W., Tyrer M., Shepherd D. Tau and tau reporters disrupt central projections of sensory neurons in Drosophila. J Comp Neurol 2000, 428:630-640.
161. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., Feany M.B. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001, 293:711-714.
162. Yu Z., Ren M., Wang Z., Zhang B., Rong Y.S., Jiao R., Gao G. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics 2013, 195:289-291.
163. Zhao X.L., Wang W.A., Tan J.X., Huang J.K., Zhang X., Zhang B.Z., Wang Y.H., YangCheng H.Y., Zhu H.L., Sun X.J., Huang F.D. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. J. Neurosci. 2010, 30:1512-1522.